Detection of galanin receptors in the spinal cord in experimental autoimmune encephalomyelitis. 2023

Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.

OBJECTIVE The neuropeptide galanin is a widely distributed neurotransmitter/neuromodulator that regulates a variety of physiological processes and also participates in the regulation of stress responses. The aims of the present study were to investigate the expression of galanin receptors (GalR1, GalR2, GalR3) in the spinal cords in a murine model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE) using qPCR analysis and to determine GalR1 cellular localization (oligodendrocytes, microglia, astrocytes, ependymal cells, and endothelial cells in the capillaries) by immunohistochemistry. METHODS Twelve samples from the EAE group and 14 samples from the control group were analyzed. Spinal cords samples were obtained at the peak of the EAE disease. RESULTS The GalR1 mRNA level was significantly decreased in the EAE mice compared with the controls (P=0.016), whereas the mRNA levels of GalR2 and GalR3 were not significantly different for the EAE and the control mice. No significant correlations were found between the severity of the EAE disease and the mRNA levels of GalR1, GalR2 and GalR3. Immunochemical detection of the GalR1 revealed its expression in the ependymal and endothelial cells. Additionally, a weak GalR1 immunoreactivity was occasionally detected in the oligodendrocytes. CONCLUSIONS This study provides additional evidence of galanin involvement in EAE pathophysiology, but this has to be further investigated.

UI MeSH Term Description Entries
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D044088 Receptors, Galanin A family of G-protein-coupled receptors that are specific for GALANIN and galanin peptides. They are generally considered to be coupled to the GI, INHIBITORY G-PROTEIN to meditate the neurological effects of galanin. Several subtypes of galanin receptors occur with differing specificities for the full length galanin, galanin peptide fragments, and galanin-like peptide. Galanin Receptor,Galanin Receptors,Receptor, Galanin
D044092 Receptor, Galanin, Type 2 A galanin receptor subtype with broad specificity for full length GALANIN, galanin peptide fragments and GALANIN-LIKE PEPTIDE. Galanin Receptor 2,GALR2 Galanin Receptor,Galanin-2 Receptor,Galanin 2 Receptor,Galanin Receptor, GALR2,Receptor 2, Galanin,Receptor, GALR2 Galanin,Receptor, Galanin-2
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D019004 Galanin A neuropeptide of 29-30 amino acids depending on the species. Galanin is widely distributed throughout the BRAIN; SPINAL CORD; and INTESTINES. There are various subtypes of GALANIN RECEPTORS implicating roles of galanin in regulating FOOD INTAKE; pain perception; memory; and other neuroendocrine functions. Galanin (1-29),Galanin (1-30)

Related Publications

Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
January 2022, Journal of neuroimmunology,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
July 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
August 2001, Neuroscience letters,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
July 2007, Journal of proteome research,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
June 2000, Journal of immunology (Baltimore, Md. : 1950),
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
January 2021, Frontiers in immunology,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
December 2013, Journal of visualized experiments : JoVE,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
March 2009, Journal of clinical neurology (Seoul, Korea),
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
October 2010, Journal of neurochemistry,
Danica Michalickova, and Ivana Kramarikova, and Hatice Kubra Ozturk, and Tomas Kucera, and Tomas Vacik, and Tomas Hrncir, and Nikolina Kutinova Canova, and Martin Sima, and Ondrej Slanar
January 2018, Folia histochemica et cytobiologica,
Copied contents to your clipboard!